Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2012
07/05/2012WO2012089882A1 Pharmaceutical composition including hyaluronic acid and a zinc compound and corresponding bar on a stick and preparation method
07/05/2012WO2012089820A1 Series of capsules comprising at least one drop of internal phase in a drop of intermediate phase and associated production process
07/05/2012WO2012089811A2 Transdermal application system comprising a protruding backing film
07/05/2012WO2012089765A1 Suspension formulations of cetyl myristate and/or cetyl palmitate
07/05/2012WO2012089764A1 A preparation method for suspension of cetyl myristate and/or cetyl palmitate
07/05/2012WO2012089763A1 Separated formulations and granulations of cetyl myristate and cetyl palmitate combination
07/05/2012WO2012089762A1 Cetyl myristate and/or cetyl palmitate granules having high bulk density
07/05/2012WO2012089761A1 Controlled moisture content of cetyl myristate and/or cetyl palmitate granules or formulations
07/05/2012WO2012089759A1 Formulations of cetyl myristate and/or cetyl palmitate particles
07/05/2012WO2012089738A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease
07/05/2012WO2012089677A1 Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
07/05/2012WO2012089537A1 Hyaluronic acid compositions stabilised against the degrading effect of heat or enzymes
07/05/2012WO2012089256A1 Medicated patch for improved transdermal permeation of diclofenac diethylammonium
07/05/2012WO2012089115A1 Moisture-retaining chinese herbal medicine composition and preparation method and use thereof
07/05/2012WO2012088992A1 Process for preparing solid medicine preparation and solid medicine preparation therefrom
07/05/2012WO2012061402A3 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
07/05/2012WO2012054923A3 Therapeutic nanoparticles with high molecular weight copolymers
07/05/2012WO2012054564A3 Anti-vegf antibody/fragment conjugated gold nanoparticles, and fabrication and therapeutic methods
07/05/2012WO2012052479A3 Brimonidine gel compositions and methods of use
07/05/2012WO2012051313A3 Ophthalmic formulations, methods of manufacture and methods of normalizing meibomian gland secretions
07/05/2012WO2012050359A3 Hydrogel particle coated with lipid and method for manufacturing same
07/05/2012WO2012048335A3 Formulation of acoustically activatable particles having low vaporization energy and methods for using same
07/05/2012WO2012040623A3 Nanostructured gels capable of controlled release of encapsulated agents
07/05/2012WO2012030513A3 Methods of treating bacterial infections through pulmonary delivery of fusidic acid
07/05/2012WO2012024526A3 Conjugates, particles, compositions, and related methods
07/05/2012WO2012006380A3 Cationic oil-in-water emulsions
07/05/2012WO2012005594A3 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides
07/05/2012WO2011156361A3 Solid dispersions containing kinase inhibitors
07/05/2012WO2011154295A3 Medical device having a counter having a preset counting range, device having counter variation
07/05/2012WO2011146852A3 Foam or particles for applications such as drug delivery
07/05/2012WO2011143118A3 Alcohol-resistant formulations
07/05/2012WO2011128633A3 Oral pharmaceutical dispersion compositions
07/05/2012WO2011084366A3 Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions
07/05/2012US20120172985 Silk fibroin hydrogels and uses thereof
07/05/2012US20120172631 Phosphatidyl oligoglycerols
07/05/2012US20120172525 Compositions containing inclusion complexes
07/05/2012US20120172364 Rate-controlled particles
07/05/2012US20120171297 Threo-dops controlled release formulation
07/05/2012US20120171296 Rapidly disintegrating solid preparation
07/05/2012US20120171295 Methods for cryopreserving and encapsulating cells
07/05/2012US20120171294 Starch foam microparticles for delivery of non-aqueous liquid to bees
07/05/2012US20120171293 Granulated material mixture comprising two different granulated materials for artificial callus distraction
07/05/2012US20120171292 Luminescent porous silicon nanoparticles for targeted delivery and immunization
07/05/2012US20120171291 Peptide-carrying nanoparticles
07/05/2012US20120171290 Hpv particles and uses thereof
07/05/2012US20120171289 Delivery systems for bioactive agents
07/05/2012US20120171288 Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
07/05/2012US20120171287 Osmotic pump controlled release tablet and preparation method thereof
07/05/2012US20120171286 Methods and compositions for the treatment and diagnosis of statin-induced myopathy
07/05/2012US20120171285 Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171283 Liposomes Useful for Drug Delivery
07/05/2012US20120171282 Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
07/05/2012US20120171281 Novel Formulations of Volatile Anesthetics and Methods of Use for Reducing Inflammation
07/05/2012US20120171280 Method of making liposomes, liposome compositions made by the methods, and methods of using the same
07/05/2012US20120171279 Strongly bound base-modified oligonucleotides
07/05/2012US20120171278 Percutaneous absorption type plaster
07/05/2012US20120171277 Abuse resistant transdermal drug delivery patch including a release-enhanced antagonist
07/05/2012US20120171275 Local administration of gallium compositions to treat pain
07/05/2012US20120171274 Transdermal patch
07/05/2012US20120171273 Oral compositions for skin benefits
07/05/2012US20120171262 Pharmaceutical formulations
07/05/2012US20120171261 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy
07/05/2012US20120171260 Stent And Delivery System With Reduced Chemical Degradation
07/05/2012US20120171259 Orally absorbed pharmaceutical formulation and method of administration
07/05/2012US20120171257 Cell-guiding fibroinductive and angiogenic scaffolds for periodontal tissue engineering
07/05/2012US20120171256 Electrospun silk material systems for wound healing
07/05/2012US20120171255 Substrate impregnated with sprayed clay, and method for manufacturing same
07/05/2012US20120171254 Process and Apparatuses for Preparing Nanoparticle Compositions with Amphiphilic Copolymers and Their Use
07/05/2012US20120171253 Fibromodulin Peptide
07/05/2012US20120171252 Oil-in-water emulsion of mometasone and propylene glycol
07/05/2012US20120171251 Sheet-form preparation and method for producing the same
07/05/2012US20120171250 Pharmaceutical composition for treating urinary system disorders
07/05/2012US20120171249 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
07/05/2012US20120171244 Mucosal boosting following parenteral priming
07/05/2012US20120171128 Dental cleaning composition
07/05/2012US20120171126 NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF
07/05/2012US20120168335 Fast Disintegrating Compositions of Meloxicam, Processes for Preparation, and Use to Treat Arthritis and/or Pain
07/05/2012DE112006004066B4 Magnetischer Träger und medizinisches Präparat zur kontrollierbaren Zuführung und Freisetzung von Wirkstoffen, Herstellungsverfahren dafür und Behandlungsverfahren unter Verwendung davon The magnetic carrier, and medical preparation for controllably supplying and release of active substances, processes for its preparation and methods of treatment using them
07/05/2012CA2823540A1 Methods for cryopreserving and encapsulating cells
07/05/2012CA2823512A1 Granulates comprising eslicarbazepine acetate
07/05/2012CA2823423A1 Moisturizing chinese herbal medicine composition, preparation method and use thereof
07/05/2012CA2823355A1 Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore
07/05/2012CA2823182A1 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
07/05/2012CA2823166A1 Orally disintegrating tablet
07/05/2012CA2823148A1 Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
07/05/2012CA2823052A1 Hyaluronic acid compositions stabilised against the degrading effect of heat or enzymes
07/05/2012CA2822854A1 Biodegradable drug delivery compositions
07/05/2012CA2822754A1 Oral pharmaceutical tablet for controlled release of mesalazine and process for obtaining it
07/05/2012CA2822528A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease
07/04/2012EP2471819A2 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
07/04/2012EP2471539A1 Transdermal composition of phosphatidylcholine and method for producing same
07/04/2012EP2471528A1 A preparation method for suspension of cetyl myristate and/or cetyl palmitate
07/04/2012EP2471523A1 Abuse resistant transdermal drug delivery patch including a release-enhanced antagonist
07/04/2012EP2471522A1 Oral dosage form providing fast absorption of drug
07/04/2012EP2471521A1 Double-layer osmotic pump controlled release tablet of bicyclol and preparation method thereof
07/04/2012EP2471520A1 Pharmaceutical compositions of levetiracetam
07/04/2012EP2471519A1 Controlled release formulation of carvedilol
07/04/2012EP2471518A2 Composition comprising oil drops
07/04/2012EP2471517A2 Rhein or diacerein compositions
1 ... 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 ... 2991